Kitagawa, Satoki
Matsuda, Teppei
Washizaki, Ayaka http://orcid.org/0000-0001-5472-5101
Murakami, Hirotomo http://orcid.org/0000-0003-0734-4298
Yamamoto, Takuya http://orcid.org/0000-0003-3753-1211
Yoshioka, Yasuo http://orcid.org/0000-0002-7265-9221
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP17H04009, JP18K19401, JP20K21480, JP20H03404)
The International Joint Usage/Research Center, Institute of Medical Science, University of Tokyo
Article History
Received: 21 October 2021
Accepted: 22 September 2022
First Online: 6 October 2022
Competing interests
: Y.Y. was employed by the Research Foundation for Microbial Diseases of Osaka University. The other authors declare no conflicts of interest.
: Animal experiments were conducted according to Osaka University’s institutional guidelines for the ethical treatment of animals and were approved by the Animal Care and Use Committee of the Research Institute for Microbial Diseases, Osaka University, Japan (protocol number, BIKEN-AP-R01-15-1). All experiments using human PBMCs were approved by the Institutional Review Board of the Research Institute for Microbial Diseases, Osaka University (protocol number 31-3-1) and were followed in compliance with the Declaration of Helsinki 1975; all participants provided written informed consent.